Cue Biopharma, Inc. License Agreements
14 Contracts & Agreements
- Rider to License Agreement, dated as of July 7, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC (Filed With SEC on August 4, 2022)
- First Amendment to the License Agreement, dated May 3, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC (Filed With SEC on August 4, 2022)
- License Agreement, March 28, 2022 (Filed With SEC on March 30, 2022)
- Third Amendment to License Agreement, dated October 22, 2021, by and between Cue Biopharma, Inc. and MIL 21E, LLC (Filed With SEC on November 9, 2021)
- First Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated October 30, 2018 (Filed With SEC on March 9, 2021)
- Second Amendment to License Agreement between the Registrant and MIL 21E, LLC (Filed With SEC on June 26, 2020)
- First Amendment to License Agreement between the Registrant and MIL 21E, LLC dated June 18, 2018 (Filed With SEC on June 20, 2018)
- License Agreement between the Registrant and MIL 21E, LLC dated January 19, 2018 (Filed With SEC on March 29, 2018)
- Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017 (Filed With SEC on December 13, 2017)
- Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017 (Filed With SEC on December 11, 2017)
- Second Amendment to Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated June 28, 2017 (Filed With SEC on September 21, 2017)
- Amendment to Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated November 14, 2016 (Filed With SEC on September 21, 2017)
- Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated July 29, 2015 (Filed With SEC on September 21, 2017)
- Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017 (Filed With SEC on September 21, 2017)
